Recommended Alerts

Sign Up For Alerts

Supreme Court Affirms Federal Circuit’s Amgen Decision: Patent Specification Must Enable the Full Scope of the Invention

On May 18, 2023, the Supreme Court issued its opinion in Amgen Inc. v. Sanofi, No. 21-757, affirming unanimously the Federal Circuit’s decision invalidating two of Amgen’s patents functionally claiming a genus of monoclonal antibodies that help reduce levels of low-density lipoprotein cholesterol (LDL, or “bad” cholesterol).

Read More

Heightened Pleading Standard of Fed. R. Civ. P.9(b) Applied to False Marking Claims

Practices: Intellectual Property

Printer-Friendly Version

Cookie Settings